USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I

Journal:

Journal of Clinical Investigation

Published:

2025-11-18

DOI:

10.1172/jci193162

Affiliations:

6

Authors:

18

Go to article

Institutions	Authors	Share
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, United States of America (USA)	12.000000 12.000000	0.67
Northwestern University (NU), United States of America (USA)	3.000000	0.17
PLA No. 920 Hospital of the Joint Support Force (PLA No. 920 Hospital), China	2.000000	0.11
Temple University, United States of America (USA)	1.000000	0.06

Interested in Oncology and Carcinogenesis?